Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Supreme Petroch.Q1 FY27Chemicals & Petrochemicals
Home/Stocks/Supreme Petroch./Q1 FY27

Supreme Petroch. Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹696P/E: 26.8Market Cap: ₹13.1K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • →The company expects demand growth primarily driven by exports, especially with appliance manufacturers setting up capacities for exports under the PLI scheme.
  • →Domestic demand from OEMs remains stable and growing, while non-OEM demand is recovering after a recent subdued phase.
  • →Expansion projects include new lines for EPS boards, compounding (especially ABS compounds), and polystyrene capacity, with all expected to be operational by March 2029.
  • →The EPS capacity phase 2 expansion is completed; new wide-width EPS board line of 150,000 m3 and compounding capacity expansion to 80,000 tons are underway.
  • →Company aims to fully utilize expanded ABS compounding capacity within 2-3 years due to sufficient market demand.
  • →Overall growth is aligned with industry's long-term positive outlook, driven by energy-efficient buildings, cold supply chain, construction, and traditional packaging.
  • →Volume guidance is not explicitly provided due to current uncertainties in global supply chain and geopolitical issues.

Margin guidance

Category 3
  • →Supreme Petrochem is expanding capacities in ABS, polystyrene, XPS boards, and compounding, with new lines expected by 2027-2029, indicating growth plans.
  • →The company anticipates demand growth driven by energy-efficient buildings, cold storages, cold supply chain, construction, exports, and traditional packaging businesses.
  • →Despite current volume declines due to non-OEM subdued demand and geopolitical supply disruptions, management expects recovery and growth over the next 2-3 years.
  • →Operating EBITDA margin improved to 19.53% in Q1 FY27 due to favorable global deltas but margins are expected to normalize as global conditions stabilize.
  • →EPS and profits benefited from widened global spreads; sustainability depends on global raw material deltas and supply chain normalization.
  • →CAPEX of ~INR 900 crores till 2029 will be funded from internal accruals, indicating financial strength to support growth.
  • →Management remains cautious about short-term guidance due to fluid geopolitical and supply dynamics but is optimistic on long-term growth and capacity utilization.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →There is no mention of any current or future fundraising through debt or equity in the earnings call transcript.
  • →All expansion projects, including new production lines and capacity increases (e.g., ABS, polystyrene, XPS, compounding), will be funded entirely through internal accruals.
  • →The total estimated investment of around INR 900 crores for ongoing expansions will be financed internally without raising debt or equity.
  • →Management reiterated that CAPEX and expansions are supported by internal cash flows, and no external financing plans were stated during the call.

Order book

The transcript provided from pages 1 to 14 of the Supreme Petrochem Limited Q1 FY27 Earnings Conference Call does not mention any details regarding the company's current or expected order book or pending orders. The discussion primarily focuses on: - Impact of global raw material price fluctuations, especially styrene monomer. - Demand trends from OEM and non-OEM segments. - Capacity expansions in EPS, polystyrene, ABS compounding, and XPS boards. - Export challenges due to geopolitical tensions and shipping constraints. - Margin sustainability and outlook amid volatile global deltas. - Capital expenditure plans and expected commissioning timelines up to 2029. No explicit information about order books or pending orders is disclosed in the available transcript.

Capex plans

Yes
  • →Supreme Petrochem is undertaking expansion projects including:
  • → - Phase 2 expansion of EPS capacity completed.
  • → - New wide-width EPS board line of 150,000 cubic meters being set up.
  • → - Compounding capacity expansion from 50,000 tons to 80,000 tons per annum, expected by June 2027.
  • → - Installation of a new 80,000 tons per annum polystyrene production line at Amdoshi complex, Maharashtra, to be completed by December 2028.
  • →Total polystyrene capacity will increase from 300,000 tons to 380,000 tons per annum after expansions.
  • →Estimated investment for these projects is INR 450 crores, funded entirely through internal accruals.
  • →Further expansions focus on ABS line 2, XPS lines, compounding lines, and a fifth polystyrene line, with all capacity additions expected by March 2029.
  • →Overall CAPEX for FY27 is planned around INR 900 crores.

How does Supreme Petroch. rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Supreme Petroch.
Rev 3Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Supreme Petroch. rank in Chemicals & Petrochemicals?

Compare Supreme Petroch. against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Supreme Petroch.

Other quarters — Supreme Petroch.

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Supreme Petroch. full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Supreme Petroch.'s management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q4 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q3 FY25 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF